Casabrain test 297

NfL as a biomarker for neurodegeneration and survival in Parkinson

Por um escritor misterioso
Last updated 30 julho 2024
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
CSF and blood biomarkers for Parkinson's disease - The Lancet
NfL as a biomarker for neurodegeneration and survival in Parkinson
IJMS, Free Full-Text
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
Frontiers Plasma Biomarkers Differentiate Parkinson's Disease
NfL as a biomarker for neurodegeneration and survival in Parkinson
Serum neurofilament light as a biomarker for prognosis in patients
NfL as a biomarker for neurodegeneration and survival in Parkinson
Frontiers Neurofilament Proteins as Biomarkers to Monitor
NfL as a biomarker for neurodegeneration and survival in Parkinson
Advances in the Research of Risk Factors and Prodromal Biomarkers
NfL as a biomarker for neurodegeneration and survival in Parkinson
Serum neurofilament light levels are predictive of all-cause
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
Association of Neurofilament Light With the Development and
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
NfL as a biomarker for neurodegeneration and survival in Parkinson
Regional free-water differentially associated with glial
NfL as a biomarker for neurodegeneration and survival in Parkinson
Neurofilament Light as a Dementia Biomarker - Practical Neurology
NfL as a biomarker for neurodegeneration and survival in Parkinson
IJMS, Free Full-Text
Recomendado para você
você pode gostar

© 2014-2024 hellastax.gr. All rights reserved.